chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen tonsils; Swollen neck lymph nodes; Sore throat; Migraines; Nerve pain; Hard bump at injection site; Fatigue; Vertigo; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 14:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The medical history included fibromyalgia, migraines, allergy to shellfish, wasp and bee stings, and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included AMOXICILLIN, SINGULAIR, MELATONIN, MEDROL, and IODINE, all from unknown dates for unknown indications and unknown if ongoing. The patient previously took LAMICTAL and LATUDA on unknown dates and experienced allergy. On 23Apr2021 at 14:30, the patient experienced swollen tonsils, swollen neck lymph nodes, sore throat, migraines, nerve pain, hard bump at injection site, fatigue, vertigo, nausea, and vomiting. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the events swollen tonsils, swollen neck lymph nodes, sore throat, migraines, nerve pain, hard bump at injection site, fatigue, vertigo, nausea, and vomiting were not resolved at the time of this report.    No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
1 wk p/vax fever & rash devel & resolved; 12 days post vax pt exp 9 minute generalized sz; fully recovered;
PT JUST CALLED AND COMPLAINED OF MUSCULAR PAIN TRAVELING TO HER NECK AND HAND AFTER THIS FLU SHOT. SAID SHE WAS IN AN ABNORMAL AMOUNT OF PAIN COMPARED TO WHEN SHE NORMALLY HAS RECEIVED FLU SHOTS AND TETANUS SHOTS. ALSO, SHE IS A NURSE AND UNDERSTANDS THAT SOME PAIN AND TENDERNESS IS NORMAL. SAYS HAS LIMITED RANGE OF MOTION. HAS TRIED TYLENOL AND ADVIL. SHE WILL KEEP AN EYE ON IT OVER THE NEXT FEW DAYS. SHE SAID ON DAY 5, THEY RESOLVED ON THEIR OWN.
Chills, body ache, headache, soreness under arm. injection site soreness - yesterday evening Sweats, headache, soreness under arm - this morning
Brain fog a few weeks after second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog a few weeks after second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog a few weeks after second shot). At the time of the report, FEELING ABNORMAL (Brain fog a few weeks after second shot) outcome was unknown. Not Provided          No concomitant medication was reported. No treatment was reported.
No known side effects; postmortem Covid-19 test negative  Date of death:  02/16/2021
No adverse reaction. Patient was given KINRIX when INFARIX should of been administered. Patient in addition received a dose of IPV.
Patient presented to the hospital on 12/29/2021 with weakness, fatigue, and cough.  Chest Xray was significant for cardiomegaly with interval enlargement.  CT of abdomen, pelvis and thorax with contrast significant for pulmonary emboli involving the left upper lobe and right lower lobe along with cardiomegaly consistent with right heart dysfunction, colonic diverticulosis and fecal impaction.  Rapid Covid-19 was positive.  Patient was admitted to hospital.  Patient had significant change in her mental status and had breakthrough seizures.  CT showed new bilateral cerebral infarcts.  Patient continued to deteriorate and required intubation, and required Levophed.  The patient expired on 01/09/2022.
Starting 06/08/2022, I woke up with a very sore throat and as the day progressed it became hard to swallow/hurt to swallow. I tested myself that day with an at-home COVID-19 test which was negative. On 06/09/2022, I felt it in my upper sinuses. I did not have a fever or headache, just was congested and had a sore throat. So, I went to urgent care thinking I had strep throat but it turned out I tested positive for COVID-19. I was tested for Influenza A and B but both came back negative. They said to treat the symptoms with ibuprofen/TYLENOL and possibly ZYRTEC. If it got worse, I was informed to go to the ER. At one point I think I had a fever but it was low grade. It took about 6 days for symptoms to resolve and I'm feeling fine today.
About 24 hours after my 2nd Moderna Vaccine, I began to feel a small nodule inside my chin, 9am the following day 9/10/22 my whole entire chin is swollen. I received, Lip and Chin Fillers from Oct- December 2021. The Lip Filler was Restylane Kiss, my Lips are normal. The chin Filler was Belotero. My chin is swollen and pain level would be at a 4. It's tolerable but very sore to touch and while talking.
Debilitating pain on the arm, headache, nausea, fast heartbeat, fever.
On day of vaccination, pt started to feel chills at night and noticed shoulder was hurting. He took an ibuprofen. The following day, pt felt warm, dizzy, and lethargic. Temp 107.5F at this time. Went to the ER and was told his temp was 103F. Pt was hospitalized at Medical Center x 2 days (ongoing). Per documentation, pt reported experiencing nausea, vomiting, dizziness. Pt was given vancomycin and ceftriaxone due to risk of infection. Pt's arm is still sore, but he notes that his symptoms are improving.
severe pain initiated as sciatica, seeked out physician care, MRI and CT performed. Seeked out pain control. Couldnt get appointment until Dec 20,2021. received pain shot on 12/23/21. Successful injection. Then started to have severe pelvic pain. Pelvic x-rays. made 2 trips to ER Received another shot  and was successful. Then more severe pelvic pain started. was unable to sleep in bed, had to walk with cane. went to ER for a urinary retention issue. Had to wear leg bag for 2 weeks until that issue turned around. My PCP was trying to figure out what was going on and had started me on Vicodin which in turn caused constipation. Many sleepless nights, much pain and a decreased life .Had an appt at a Center for Neurosciences. Took 2.5 months to get appt. Had an EMG/NCT. of right leg.  Was negative and neurologist said nothing wrong dont need to return.  Went to a new pain place and had a bilateral superior hypogastric plexus block. Was unsuccessful so far. Still seeking answers..
Have had elevated sugar levels a few days after having the first dose. Have just seen my PCP to take necessary steps
Upon reviewing patient's need for 2nd dose of Moderna, patient's power of attorney informed me that the patient passed away on 5/11/21 without any further information disclosed.
pt recv vax; 2 hrs later T of 101.5;pallor;poor fusion, completely limp; tonic/clonic movements x 1 min; sz episode; mom describes a 2 hr period during which color and tone remained abnormal;
a lot of mucus in her nose/constantly blowing nose/mucous coming out; phlegm in nose/a lot of flem/flem was beige; mucous in her throat with beige black spots; headache; feels like a flu; coughing a lot; feeling "tired, and cold and hot".; feeling "tired, and cold and hot".; This is a spontaneous report from a contactable consumer (patient). The reporter also reports on her husband and her mother and husband's brother.   A 65-year-old female patient received BNT162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number, Expiration and NDC number date was not reported), via an unspecified route of administration on 01Mar2021 as dose 1, single (at the age of 65-year-old) for COVID-19 immunisation. Medical history included spinal fusion (last year) from 2020 to an unknown date. The family history included husband was diabetic, has heart problems, Chronic Obstructive Pulmonary disease (COPD), and overweight. Historical vaccine included patient received flu shot (Influenza vaccine) (54 when she had to get the flu shot) on an unknown date for immunisation. The patient's concomitant medications were not reported. Patient was not a sickly person. On Mar2021, a week later, patient had chills, mucous coming out/a lot of mucus in her nose, phlegm in nose/phlegm in nose/a lot of flem/flem was beige and still has it, mucous in her throat with beige black spots, feeling tired, and cold and hot.  Patient adds that she has not had any chills.  On an unspecified date of 2021, patient had a headache, was probably coughing and feels like a flu. Phlegm was still coming out, mucous was still there. Patient was constantly blowing her nose and constantly hacking mucous. Patient does not have a primary care doctor, she does not go around, she keeps her mask on, and stays in the house. Patient adds that she thinks the thing was that she was scheduled to see her neurosurgeon today (19Mar2021), this morning but was going to cancel because even if this was a cold she does not want to go in there or give anybody anything.  Patient adds that she does not have a fever, she just does not know.  Patient talked to the secretary at the physician's office and did not want to go there and give them anything. Patient was scheduled for her second vaccination dose on Monday (22Mar2021) and she hopes that nobody tells her not to go because that means that her first dose will not work and she would have to start all over again. Patient adds that she would like to speak to somebody about if she should take the second vaccine. She adds it took her 50 years to get her flu shot, she was 54 when she had to get the flu shot. She did not want something to happen to her and then her family will not take the vaccine.  She just wanted to know if something happens to her. The outcome of phlegm in nose/a lot of flem/flem was beige was not recovered and unknown for rest of the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This literature marketed report was received from the authors in a published literature article,  concerning a 12-year-old girl with a history of relapsed acute myeloid leukaemia (AML) presented 2 years status post-unrelated haematopoietic cell transplantation (HCT) for immune evaluation and assessment of readiness to receive live vaccinations. At the age of 10 years, she received a matched unrelated bone marrow transplant. She received myeloablative conditioning with busulfan and cyclophosphamide along with immunosuppression with alemtuzumab, tacrolimus and methotrexate for prevention of graft versus host disease (GVHD). Alemtuzumab was discontinued shortly thereafter because of rash and fever thought to be due to it. She received three total doses of methotrexate (5.6 mg). She had a complicated immediate post-transplant course, which included infections with Clostridium difficile and adenovirus. She also developed GVHD that manifested first as diarrhoea with mild GVHD on duodenal biopsy and was initially treated with ongoing tacrolimus and oral budesonide. Complete donor chimerism was achieved by 100 days post-HCT. Seven months post-transplant, she developed chronic GVHD with maculopapular rash involving <50% of skin surface and was treated with oral prednisone and subsequently briefly with rituximab. Tacrolimus was also continued at varying doses with a maximum of 1 mg twice daily, tapered down over several months and discontinued for the final time 573 days after transplant. Prednisone was started 207 days after transplant at a dose of 20 mg twice daily and was tapered down and discontinued 323 days after transplant. She had mild hypogammaglobulinaemia treated briefly with intravenous immunoglobulin. She was off of all immunosuppression at the time of her vaccination-readiness immune evaluation. On an unknown date, the patient was given live vaccination with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) and VARIVAX, 0.5 mL for prophylaxis (route, lot# and the expiration date were not reported). She returned to an outside facility 10 days later with localized rash consistent with Varicella infection, subsequently confirmed to be vaccine strain (oka/ Merck strain) (varicella post vaccine). This patient had an initial immune evaluation 2 years after transplant, which was reassuring for apparently normal immune reconstitution. However, she developed localized Varicella infection soon after vaccination (vaccination failure). Serial assessment 7 months later demonstrated improvement in T-cell function, and subsequent vaccination was without incident or further infection. At the time of reporting, the outcome of varicella post vaccine and vaccination failure was not provided.
Persistent vomiting and PO intolerance in a 4 month old infant.  Intussusception was demonstrated by abdominal ultrasound.  An air enema was done and successfully reduced the intussusception. The tests and procedure were through the Hospital. emergency room.
Increase in blood pressure/ spiked; This is a spontaneous report from a contactable consumer (patient). This consumer reported information for both mother and fetus/baby. This is the maternal report. A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 03May2021 as 2nd dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took Penicillin and experienced Allergy. The patient previously received TDAP vaccine on 03Mar2021 and first dose of BNT162B2 on 02Apr2021 for COVID-19 immunisation and experienced Increase in blood pressure/preeclampsia (11:00 AM, lot number: Ep7833). The patient experienced increase in blood pressure in May2021. Blood pressure returned to normal levels 3 weeks post-partum and spiked again after 2nd shot on 03May2021. Treatment was received for the event which included BP medication. The patient was hospitalized for 7 days for the event. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the event was unknown.   Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021516156 same report, mother/fetus case.
Systemic: Rash (other than injection site)-Mild, Systemic: Other- Elevated heart rate, difficulty swallowing, nurse reports mental status changes-Mild
dizziness; weakness.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and ASTHENIA (weakness.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness) and ASTHENIA (weakness.). At the time of the report, DIZZINESS (dizziness) and ASTHENIA (weakness.) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Patient demographics, outcome of events updated On 11-May-2021: No new information
This spontaneous report was received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot # M043424, expiry date 06-JUN-2018, lot # M026317 expiry date 11-JAN-2018) for prophylaxis since 15-MAR-2017. No adverse events were reported. Temperature of 47 degree Fahrenheit to 77 degree Fahrenheit and time frame was 6.5 hours. There was no previous temperature excursion. It was stated that it was because of data logger. This is one of the several reports received from the same reporter. Additional information has been requested.
Participant was given 1 ml flu vaccine instead of required dose of .5ML; over dosage of influenza vaccine.
Patient said he had no energy to do anything; Patient said that he was beat and tired; started having severe after effects on him last night; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (started having severe after effects on him last night), ASTHENIA (Patient said he had no energy to do anything) and FATIGUE (Patient said that he was beat and tired) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 064A22A, 939904, 023C21A and 016C21A) for COVID-19 prophylaxis.     Patient had No allergies, and no other medical history was reported. Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was reported as No.  The patient's past medical history included COVID-19 (Positive Covid test) in January 2021. Concomitant products included ATORVASTATIN CALCIUM (AVASTATIN), METOPROLOL SUCCINATE, OXYBUTYNIN CHLORIDE, MINOCYCLINE HYDROCHLORIDE (MINOCYCLINE HCL), AMLODIPINE BESYLATE, WARFARIN and GABAPENTIN for an unknown indication.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 14-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jul-2022, the patient experienced IMMUNISATION REACTION (started having severe after effects on him last night). On 19-Jul-2022, the patient experienced ASTHENIA (Patient said he had no energy to do anything) and FATIGUE (Patient said that he was beat and tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, IMMUNISATION REACTION (started having severe after effects on him last night) outcome was unknown and ASTHENIA (Patient said he had no energy to do anything) and FATIGUE (Patient said that he was beat and tired) had not resolved.            Patient concomitant medication was reported as Revamptin for an unknown indication.  It was reported that patient had received his 2nd booster dose of the Moderna COVID-19 vaccine and on 18-Jul-2022, patient started having severe aftereffects on him during the night. Today, on 19-Jul-2022, he is beat and tired. He says that he has no energy to do anything.   Patient did not went to ER and was not hospitalized due to the events Beat and Tired/no energy and patient symptoms (Beat and Tired/no energy )were worsened.   This case was linked to MOD-2021-090388, MOD-2021-163737 (Patient Link).
23AUG94 according to client's mom pt had stomach cramps, vomited 8x in the next hr c/o pain in lt arm, lt leg , lt side; c/o lt sided numbness; mom reports t101 to 102 oral;
Hard area at the site with an urticarial rash throughout her trunk and extremities. Advised to give low dose of BENADRYL.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.; Sender's Comments: This case concerns a 73-year-old patient, unknown gender, with no known medical history, who experienced the non-serious event of expired product administered. The event occurred  on the third day after unspecified dose of mRNA 1273 vaccine. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 02-SEP-2014 the patient was vaccinated with a dose of VAQTA (lot number, expiration date, dose, route were not reported) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pain, itching, redness, swelling started one week after receiving the vaccine. No other reactions prior. Got better with antibiotic and then worsened today (1/27/21). Redness spread and more pain and itching. Hot to touch. Will start taking a prescribed anti-inflammatory.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients who were administered vaccines which were stored improperly. This report refers to the patients who on unknown dates were vaccinated with PNEUMOVAX 23 that were stored improperly. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
Patient came to the pharmacy and visually showed severe black/blue bruising on her deltoid from her recent COVID-19 Pfizer vaccine given on 07/30/2021 by a pharmacy technician. In addition, she mentioned that at the time of vaccination, technician did not retract the needle quickly and may have wiggle. The patient stated that the bruising started shortly after her vaccination and gradually got worse. Patient reports swelling and pain that radiates up her arm towards her neck. She is considering going to her primary care provider for consult as well as her chiropractor since she assumes this may have caused a nerve issue.
Headache, Arthralgia, NauseaVomiting, Chills, left arm sore Narrative:  Other Relevant History: